Columns

Session 6: What Is True Marketing?

2025.01.09
【Hisashi Iwase】 For someone like me in my 40s, caught up in the whirlwind of dramatic corporate mergers and acquisitions, these experiences became invaluable to my social and professional life thereaft… 黒澤伸行

Columns

Session 5: The Beginning of a New Survival Era

2025.01.15
【Hisashi Iwase】 In June 2007, PerSeptive Biosystems Japan Corporation received the “No. 1 Sales Award.” A total of 14 members, including all sales representatives and marketing team members, were invited to the U.S. head.… 黒澤伸行

Columns

Session 4: Contributing to the Launch of U.S. Venture Companies

2025.01.15
【Hisashi Iwase】 PerSeptive Biosystems was likely named by combining “Perfusion” and “Perspective” to create the term “PerSeptive.” The founder, Dr. Noubar Afeyan, was only 30 years old at the time. After graduating fro… 黒澤伸行

Columns

Session 3: Corporate Acquisitions and Spin-Outs to Ventures

2025.01.15
【Hisashi Iwase】 On a summer evening in July 1995, my colleague, Sales Manager Mr. Y, and I were in a Boston sports bar, reflecting on the day with Samuel Adams beers in hand.“So, what… 黒澤伸行

Columns

Session 2: The Biobusiness Battle in the Second Half of the 20th Century

2025.01.15
【Hisashi Iwase】 By the 1990s, Japanese research institutions considered four essential instruments indispensable for bioresearch. These “Four Essential Tools” referred to the DNA sequencer, DNA synthesizer, protein sequ 黒澤伸行

Columns

Session 1: Was Japan Truly a Loser in 20th-Century Biotechnology?

2024.07.18
【Hisashi Iwase】 At the end of the 20th century, science and technology made immeasurable strides in the field of life sciences. The declaration of the completion of the Human Genome Project was hailed as a monumental ach… 黒澤伸行